Document is current

Article History

First Online: 27 June 2025

Competing interests

: H.O.D.C. has received clinical research support for laboratory consumables and staff from Bayer AG and provides consultancy/advisory board advice (all paid to Institution; no personal remuneration) to Bayer AG, PregLem SA, Gedeon Richter, Vifor Pharma UK Ltd, AbbVie Inc., Myovant Sciences GmbH, and BioInnovations Institute (BII; Copenhagen). H.O.D.C. has received royalties from UpToDate for an article on abnormal uterine bleeding; and is the current chair of the Wellbeing of Women’s Research Advisory Committee. L.R. is Women’s Health Ambassador for England, chair of Wellbeing of Women, and a non-executive director of NHS Resolution. M.G.M. provides advice to Pharmacosmos (consultant, grant support), Daiichi Sankyo, Shield Therapeutics, and is founder and chair of the Women’s Health Research Collaborative. M.L. has served as a consultant for Sobi, CSL Behring, Takeda, and Band Therapeutics, received speaker fees from Sobi and Takeda, and research funding from Takeda. A.M. provides advisory board advice for AbbVie and Pfizer. I.R. and M.K.G. have no competing interests.